Impact of Switching to Fingolimod Versus Injectable Disease-Modifying Therapy Cycling on Risk of Multiple Sclerosis–Related Relapses: A Retrospective Analysis

Maria Cecilia Vieira,Yunfeng Li,Xiangyi Meng,Huanxue Zhou,Olivia Wenxian Piao,Christen Kutz,Devon S. Conway

Impact of Switching to Fingolimod Versus Injectable Disease-Modifying Therapy Cycling on Risk of Multiple Sclerosis–Related Relapses: A Retrospective Analysis

2020

Maria Cecilia Vieira
Yunfeng Li
Xiangyi Meng
Huanxue Zhou
Olivia Wenxian Piao
Christen Kutz
Devon S. Conway

Background: Clinical and real-world studies have shown significant reductions in MS relapses in patients receiving fingolimod versus injectable disease-modifying therapies (iDMTs). The objective wa...

Keywords:

in patient
Multiple sclerosis
Disease
Internal medicine
Fingolimod
retrospective analysis
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations